Paradigms in androgen/castrate resistant states of prostate cancer in a biomarker era-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Paradigms in androgen/castrate resistant states of prostate cancer in a biomarker era

Published:2008-07 Issue:4 Volume:26 Page:408-414
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Bianco Fernando J.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference64 articles.

1. Cancer statistics, 2008;Jemal;CA Cancer J Clin,2008

2. Prostate specific antigen only progression of prostate cancer;Moul;J Urol,2000

3. Secondary hormonal therapy for advanced prostate cancer;Lam;J Urol,2006

4. Prognosis after androgen deprivation therapy in men with a rising PSA after prostatectomy;Bianco;Proc Am Soc Clin Onc,2005

5. Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: Data from Southwest Oncology Group Trial 9346 (INT-0162);Hussain;J Clin Oncol,2006

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiopharmaceuticals for the Diagnosis and Therapy of Neuroendocrine Differentiated Prostate Cancer;Current Radiopharmaceuticals;2017-03-08

2. Inhibition of Circulating Dipeptidyl Peptidase 4 Activity in Patients with Metastatic Prostate Cancer;Molecular & Cellular Proteomics;2014-11

3. Novel Prognostic Markers in the Serum of Patients With Castration-Resistant Prostate Cancer Derived From Quantitative Analysis of the Pten Conditional Knockout Mouse Proteome;European Urology;2011-12

4. Clinical Trial Update and Novel Therapeutic Approaches for Metastatic Prostate Cancer;Current Medicinal Chemistry;2011-10-01

5. Do we have to withdraw antiandrogenic therapy in prostate cancer patients before PET/CT with [11C]choline?;European Journal of Nuclear Medicine and Molecular Imaging;2011-09-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3